Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Calidi Biotherapeutics, Inc. Common Stock (NY:CLDI)

0.2500 -0.0002 (-0.08%)
Streaming Delayed Price Updated: 11:30 AM EDT, Apr 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 857,044
Open 0.2473
Bid (Size) 0.2500 (3,900)
Ask (Size) 0.2501 (100)
Prev. Close 0.2502
Today's Range 0.2420 - 0.2608
52wk Range 0.2027 - 7.250
Shares Outstanding 7,167,721
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
New AI Tool Could Boost the Early Detection of Lung Cancer
Via Investor Brand Network
Topics Artificial Intelligence
New Urine Test Boosts Forecasting of Treatment Outcomes in Bladder Cancer
Via Investor Brand Network

Performance

YTD
-78.8%
-78.8%
1 Month
-15.3%
-15.3%
3 Month
-75.2%
-75.2%
6 Month
-84.4%
-84.4%
1 Year
-43.2%
-43.2%

More News

Read More
Immunotherapy Could Be Boosted by Blocking the Removal of Cancer RNA
Via Investor Brand Network
News headline image
RedChip's April 16 Virtual Investor Conference to Feature Companies Advancing Clinical Pipelines and Scalable Healthcare Platforms
Via ACCESS Newswire
Report Forecasts the Cancer Immunotherapy Market Hitting $311.4B by 2031
Via Investor Brand Network
Scientists Discover Why Immunotherapy Frequently Fails
Via Investor Brand Network
Research Suggests the Thymus is Critical in Immunotherapy Outcomes
Via Investor Brand Network
Topics Artificial Intelligence
Major Discovery Could Reshape Cancer Immunotherapy
Via Investor Brand Network
Oncolytic Virus Therapy is Set to Transform Cancer Care
Via Investor Brand Network
Scientists Discover Why Colon Cancer Diagnoses are Increasing in Young Adults
Via Investor Brand Network
Microbial Ecosystems Play a Big Role in the Efficacy of Cancer Immunotherapy
Via Investor Brand Network
Unusual volume stocks in Tuesday's session ↗
Via Chartmill
Ongoing Digital Monitoring Could Make Immunotherapy More Accessible
Via Investor Brand Network
OSU Researchers Develop Nanomaterial That Eliminates Cancer Cells
Via Investor Brand Network
UCLA Researchers Develop Method to Fix Fuel Shortages in Cancer Immunotherapy
Via Investor Brand Network
Engineered Nanoparticles Hold Promise in Delivering Precision Cancer Treatments
Via Investor Brand Network
Cancer Stress Protein Enables Tumors to Evade the Immune System
Via Investor Brand Network
Existing Cancer Drug Shows Potential in Reactivating Immunotherapy
Via Investor Brand Network
Early Symptoms of Lung Cancer You Could Be Ignoring
Via Investor Brand Network
Novel Yeast Cell Platform Promises to Expedite the Development of Immunotherapies
Via Investor Brand Network
Circadian Regulation Could Boost Cancer Immunotherapy, New Study Finds
Via Investor Brand Network
Novel Therapy Helps Tumor Cells Welcome Cancer Treatment
Via Investor Brand Network
Scientists Develop Next-Gen Antibodies That Boost the Body’s Cancer Killing Cells
Via Investor Brand Network
Study Discovers Molecule of Gut Bacteria That Boosts Immunotherapy Response
Via Investor Brand Network
Cornell Researchers Develop Particles That Can Supercharge Immunotherapy
Via Investor Brand Network

Frequently Asked Questions

Is Calidi Biotherapeutics, Inc. Common Stock publicly traded?
Yes, Calidi Biotherapeutics, Inc. Common Stock is publicly traded.
What exchange does Calidi Biotherapeutics, Inc. Common Stock trade on?
Calidi Biotherapeutics, Inc. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Calidi Biotherapeutics, Inc. Common Stock?
The ticker symbol for Calidi Biotherapeutics, Inc. Common Stock is CLDI on the New York Stock Exchange
What is the current price of Calidi Biotherapeutics, Inc. Common Stock?
The current price of Calidi Biotherapeutics, Inc. Common Stock is 0.2500
When was Calidi Biotherapeutics, Inc. Common Stock last traded?
The last trade of Calidi Biotherapeutics, Inc. Common Stock was at 04/21/26 11:30 AM ET
What is the market capitalization of Calidi Biotherapeutics, Inc. Common Stock?
The market capitalization of Calidi Biotherapeutics, Inc. Common Stock is 1.79M
How many shares of Calidi Biotherapeutics, Inc. Common Stock are outstanding?
Calidi Biotherapeutics, Inc. Common Stock has 2M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback